Rheumatoid arthritis, axial spondyloarthritis Musculoskeletal Diseases Rheumatoid arthritis, unspecified
Conditions
Interventions
Participants will be informed about the study and after checking eligibility criteria and signing informed consent they will be able to participate. They will receive a mobile application to access he
Sponsors
Sociedad Española de Reumatología
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Over 18 years of age 2. Have a smartphone or tablet-type cell phone 3. Accepting participation in the study and signing the informed consent form 4. Patients under follow-up for at least 1 year in the Complex Therapies Unit of the Rheumatology service with a diagnosis of rheumatoid arthritis, spondyloarthritis, or psoriatic arthritis
Exclusion criteria
Exclusion criteria: 1. Not owning a mobile device compatible with the mHealth solution 2. Not being able to participate in the program without assistance
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Impact of the mobile solution on patients’ satisfaction, measured using an ad-hoc questionnaire at 6 months 2. Engagement at an aggregated level measured continuously via users’ login frequency from recruitment until drop-out or the end of the follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Quality of life measured by Health Assessment Questionnaire (HAQ) at baseline, 1, 2, 3, 4, 5 and 6 months 2. Disease activity measured by Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) at baseline, 1, 2, 3, 4, 5 and 6 months | — |
Countries
Spain
Outcome results
None listed